03 Profile
Vital Signsby Bridgehead
Hansard to 9 November 2026 · 31,243 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Diabetes
Dr Robert Weinreb: no photograph is held, so the academic plate is shown instead.
Academic
Dr Robert Weinreb
Chair and Distinguished Professor of Ophthalmology at University of California, San Diego
1
0
Oct 2026Nov 2026to date
1
press citation on 1 topic since 9 Oct 2026 · last quoted 9 Oct 2026
02 Quoted on · 1 of 29 topics
Dr Robert Weinreb: key facts
- Kind of voice
- Academic
- Role
- Chair and Distinguished Professor of Ophthalmology at University of California, San Diego
- Quoted on
- Diabetes
- Tracked press citations
- 1
- Most recently quoted
- 9 Oct 2026
04 The signal · where Dr Robert Weinreb sits on diabetes
Ranked 45= of 100 voices quoted in the press on diabetes, level with 55 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Douglas TwenefourClinicianHead of Clinical, Diabetes UK11 - 2
Helen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)9 - 3
Parth NarendranAcademicProfessor of Diabetes Medicine; Honorary Consultant Physician (leads the Type 1 Diabetes clinical service at the Queen Elizabeth Hospital Birmingham), University of Birmingham7 - 45=Damola AjeAcademicMassachusetts-based endocrinologist1
- 45=William HsuAcademicendocrinologist and chief health officer for biotech company L-Nutra1
- 45=Dr Robert WeinrebAcademicChair and Distinguished Professor of Ophthalmology at University of California, San Diego1
- 45=Dr Stella SarrafSector leaderChief Executive Officer and Founder, Spinogenix1
- 45=Subrata BasuClinicianClinical director, Central Basildon PCN (Dr)1
Showing the leaders and the ranks around 45=, of 100 voices · See every voice on the topic →
05 On the record · press
What Dr Robert Weinreb has said
By outlet · linked articles
- drugtargetreview.com1
Where Dr Robert Weinreb has been quoted
- 01Tazbentetol shows retinal neuroprotection potential in diabetic mouse modeldrugtargetreview.com · 9 Oct 2026
Verbatim
“Synapse loss is increasingly recognised as an early and important driver of neurodegeneration across retinal diseases, including diabetic retinal neuropathy. These findings build on prior work in a model of glaucoma and demonstrate the ability of tazbentetol to preserve retinal ganglion cells, maintain synaptic integrity and protect retinal function in response to diverse neuronal stressors.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- First UK patient treated with NICE approved TeplizumabUniversity of Birmingham
- Branding update for insulin pensDiabetes Research & Wellness Foundation
- DRWF Events: Register now for Diabetes: A Whole Life BlueprintDiabetes Research & Wellness Foundation
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.